MorphoSys to Host Conference Call to Discuss New Strategic Alliance with Novartis

MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment) yesterday announced the formation of one of the most comprehensive strategic alliances in the discovery and development of biopharmaceuticals with Novartis. The deal is aimed at establishing a pipeline of innovative drugs, and combines MorphoSys's and Novartis's research, development, manufacturing and commercialization capabilities. In order to provide detailed information on this announcement the Management Board of MorphoSys AG will host a public conference call and live audio webcast on Monday, December 03, 2007 at 10:00 CET. Dial-in number: +49 (0)69 9897 2623 (listen-only) UK residents: +44 (0)20 7138 0844 Confirmation code: 8460477 The call will be hosted by: Dr. Simon Moroney, Chief Executive Officer Dave Lemus, Chief Financial Officer MorphoSys AG offers participants the opportunity to follow the presentation through a simultaneous slide presentation online at The presentation slides will be available on the Company's website. A slide-synchronized audio replay of the conference will be available following the live event on For further information please contact: Dr. Claudia Gutjahr-Löser, Head of Corporate Communications, Tel: +49 (0) 89 / 899 27-122, or Mario Brkulj, Manager Public Relations, Tel: +49 (0) 89 / 899 27-454,